D
Cytokinetics, Incorporated CYTK
$38.34 $0.290.76% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 16.73% -7.57% 6.56% -12.02% -5.66%
Total Depreciation and Amortization -0.65% -3.48% -1.16% 0.21% 3.22%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 68.27% -19.06% -13.68% 46.86% 7.88%
Change in Net Operating Assets -882.34% -112.47% 322.04% 1.20% 138.00%
Cash from Operations 2.57% -100.73% 35.40% -2.20% 23.31%
Capital Expenditure 26.82% -339.07% -84.02% 63.39% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -48.91% -0.48% 352.87% 93.17% -2,090.24%
Cash from Investing -50.09% -4.43% 346.07% 93.09% -2,096.10%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 6.45% 1.03% -0.69% -0.56% -208.80%
Issuance of Common Stock -11.84% 18.07% 2.55% -98.99% 406.52%
Repurchase of Common Stock -3,853.85% 98.90% -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -100.00% --
Cash from Financing 1,551.94% 99.41% -30.39% -99.58% 691.02%
Foreign Exchange rate Adjustments -152.59% -192.47% 331.75% -887.50% -40.74%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 111.79% -144.15% 133.49% -304.16% 909.29%